Literature DB >> 7284990

Cytokinetic and cytotoxic effects of antimetabolites on 9L rat brain tumor cells in vitro.

M Weizsaecker, T Hoshino, D F Deen, S Kobayashi.   

Abstract

Treatment of exponentially growing 9L monolayer cells with graded concentrations of methotrexate or 5-fluorouracil (5-FUra) resulted in approximately 95% cell kill, corresponding to the percentage of cells in this system labeled by autoradiography (98%). Additional cell kill could be obtained if 5-FUra was administered at a high concentration (7.7 x 10(-4) M) and could be partly reversed in the presence of 8.2 x 10(-5) M uridine. When cell kill was measured as a function of time of exposure, a 3-hr exposure to 2.2 x 10(-4) M methotrexate or 7.7 x 10(-6) or 10(-4) M 5-FUra killed 30 to 50% of the cell population, which is equivalent to the percentage of the S-phase cells of the system. With both agents, additional cell kill was offset by division of unaffected G2 cells and a drug-induced block of G1 cells at the G1-S border, and it depended on long drug exposure. Nontoxic concentrations of 5-FUra could synchronize and increase the fraction of cells in the drug-sensitive S phase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  Experimental combination chemotherapy with thymidylate synthetase and ribonucleotide reductase inhibitors.

Authors:  S Kobayashi; T Hoshino; D V Santi
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

2.  Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukemia cells.

Authors:  M Tsurusawa; M Niwa; N Katano; T Fujimoto
Journal:  Jpn J Cancer Res       Date:  1990-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.